Survival and graft‐versus‐host disease in patients receiving peripheral stem cell compared to bone marrow transplantation from <scp>HLA</scp>‐matched related donor: retrospective analysis of 334 consecutive patients

Our results confirm previous findings of increased chronic GVHD incidence in patients receiving PBSC when compared to patients receiving BM as the graft source in HSCT. Acute GVHD incidence, progression-free survival and overall survival were not different between the groups.